Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 60
Updated:4/2/2016
Start Date:October 2010
End Date:October 2013
Contact:Abhishek Choudhary, MD
Email:choudharya@health.missouri.edu
Phone:573 882 7349

Use our guide to learn which trials are right for you!

The central hypothesis of this proposal is that a reduction in hepatic mitochondrial
function is the main pathophysiology behind NAFLD (Non-Alcoholic Fatty Liver Disease) and
NASH (Non alcoholic steatohepatitis). The investigators further hypothesize that lifestyle
modifications through aerobic exercise training without weight loss or diet-induced weight
loss are effective in reducing NAFLD parameters by improving hepatic mitochondrial content
and function in human subjects.

The investigators propose a randomized, controlled human clinical trial to compare the
effects of aerobic exercise training (without weight loss) versus diet-induced weight loss
(without exercise) in individuals who have NAFLD or liver biopsy-confirmed NASH

Fatty Liver Disease) and NASH (Non alcoholic steatohepatitis). The investigators further
hypothesize that lifestyle modifications through aerobic exercise training without weight
loss or diet-induced weight loss are effective in reducing NAFLD parameters by improving
hepatic mitochondrial content and function in human subjects.

The investigators propose a randomized, controlled human clinical trial to compare the
effects of aerobic exercise training (without weight loss) versus diet-induced weight loss
(without exercise) in individuals who have NAFLD or liver biopsy-confirmed NASH

Inclusion Criteria:

- sedentary individual between

- age group 18-60 years old

- elevated Liver Function Tests (LFT's) with fatty liver on ultrasound and biopsy
proven NASH

Exclusion Criteria:

- significant history of alcohol consumption > 20 gm/day (> 2 drinks / day)

- evidence of other causes of hepatitis including positive screening B & C, autoimmune
hepatitis, hemochromatosis, celiac disease, Wilson's disease, alpha 1 antitrypsin
deficiency or medication-induced hepatitis

- Subjects with planned exercise > 30-60 minutes per week

- BMI < 25 or > 44 kg/m2

- clinical or biochemical evidence of decompensated liver disease, advanced cardiac or
renal disease

- changes in last 3 months the dose of oral hypoglycemic medication and statin,

- positive stress test

- pregnant women

- demented individuals who cannot give consent
We found this trial at
1
site
Columbia, Missouri 65212
?
mi
from
Columbia, MO
Click here to add this to my saved trials